Most recent stories

• Lawsuit puts flu-vaccine contract in doubt

  Biotech company sued by creditors.

  30 June 2009

• Has NIH funding improved public health? - Premium content

  Increased funding for biomedical research boosts health and economy, researchers claim.

  22 June 2009

• Drug quells anxiety in early trials - Premium content

  Angst-fighting compound lacks side effects of current treatments.

  18 June 2009

• Research parks feel the economic pinch - Premium content

  Once lauded as incubators of high-tech jobs, science parks find themselves struggling in the new financial environment.

  17 June 2009

• Sexual gene shuffling suppressed in plants - Premium content

  Asexual cell division could hold the key to a breakthrough in plant breeding.

  09 June 2009

• Drug giants unite to develop cancer therapy - Premium content

  Merck and AstraZeneca collaboration could launch a new trend — if their work yields results.

  02 June 2009

• Flaws found in mouse model of diabetes - Premium content

  Missing protein could limit the use of mice in studies of the disease.

  28 May 2009

• Old seasonal flu antibodies target swine flu virus - Premium content

  Lab results could explain why young patients are hardest hit by current H1N1 strain.

  21 May 2009

• Swine flu spread matches previous flu pandemics - Premium content

  New analysis supports pandemic designation.

  11 May 2009

• How thalidomide makes its mark - Premium content

  Drug's effects on embryonic blood-vessel growth may be the source of malformed limbs.

  11 May 2009

• Cyberinfrastructure: Feed me data - Premium content

  The iPlant programme was designed to give plant scientists a new information infrastructure. But first they had to decide what they wanted, finds Heidi Ledford.

  24 June 2009

• Microscopic marvels: The naked microscope - Premium content

  03 June 2009

• Translational Research: The full cycle - Premium content

  Results can be thrust from bench to bedside, but there is also much to be learned by pushing the other way. Heidi Ledford tells tales of clinical trials that have prompted a change in tack.

  11 June 2008

• Collaborations: With all good intentions - Premium content

  Collaborations spawn fresh ideas and boost productivity - most of the time. Heidi Ledford examines what happens when a working relationship breaks down, and asks how to avoid it.

  09 April 2008

• Biotechs go generic: The same but different - Premium content

  As several lucrative protein-based drugs are poised to go off patent, makers of biopharmaceuticals argue that their products are too complex to be reproduced as generics. Heidi Ledford investigates how close 'biosimilar' drugs can get to the original.

  19 September 2007